POLYPHOR AG Spexis to present at BioEquity Europe 2022
Transparency directive : regulatory news
|
Spexis AG
/ Key word(s): Conference
Allschwil, Switzerland, May 12, 2022 Spexis to present at BioEquity Europe 2022 Spexis AG (SIX: SPEX) today announced that that the company will present at BioEquity Europe, taking place May 17 & 18, 2022. Jeff Wager, CEO of Spexis, will provide an overview of the company and its pipeline and will be available to participate in one-on-one meetings with investors who are registered to attend the conference. The presentation is now available to conference registrants. For more information on the conference, visit the BioEquity website.
About Spexis
End of Media Release |
| Language: | English |
| Company: | Spexis AG |
| Hegenheimermattweg 125 | |
| 4123 Allschwil | |
| Switzerland | |
| Phone: | +41 61 567 1600 |
| Fax: | +41 61 567 1601 |
| E-mail: | info@spexisbio.com |
| Internet: | www.spexisbio.com |
| ISIN: | CH0106213793 |
| Valor: | SPEX |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 1350291 |
| End of News | EQS News Service |
|
|
1350291 12.05.2022